Product Recalls in New Hampshire

Product recalls affecting New Hampshire — including food, drugs, consumer products, medical devices, and vehicles distributed to New Hampshire. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,552 recalls have been distributed to New Hampshire in the last 12 months.

49,311 total recalls
2,552 in last 12 months

Showing 61416160 of 13,374 recalls

DrugDecember 5, 2018· Pharmedium Services, LLC

Recalled Item: Fentanyl Citrate 2 mcg per mL (200 mcg per 100 Recalled by Pharmedium...

The Issue: Sub-potent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 4, 2018· Epic Pharma, LLC

Recalled Item: Estradiol Tablets Recalled by Epic Pharma, LLC Due to Presence of foreign...

The Issue: Presence of foreign tablet/capsule: A single foreign tablet was found in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 30, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Amlodipine and Olmesartan Medoxomil Tablets Recalled by Aurobindo Pharma USA...

The Issue: Discoloration: This product is being recalled due to a confirmed pharmacist...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 30, 2018· VistaPharm, Inc.

Recalled Item: NYSTATIN Oral Suspension Recalled by VistaPharm, Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications:Out of specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 5 mg/160 mg Recalled by Teva...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 10 mg/160 mg Recalled by Teva...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 5 mg/320 mg Recalled by Teva...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 10 mg/320 mg (a) 30-count bottles Recalled...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine Recalled by Teva Pharmaceuticals USA Due to CGMP Deviations: FDA...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2018· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Aprepitant Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: Shortfill: Aprepitant capsules 40 mg is being recalled due to customer...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 26, 2018· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2018· Tris Pharma Inc.

Recalled Item: infants* IBUPROFEN Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2018· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen Recalled by Tris Pharma Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: fas.TRACT Coagulative Hemostatic Gel Recalled by CAO Group, Inc. Due to cGMP...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: BeeGentle Honey Flavored Topical Anesthetic Recalled by CAO Group, Inc. Due...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: SHEER DesenZ Desensitizing Treatment Recalled by CAO Group, Inc. Due to cGMP...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 16, 2018· CAO Group, Inc.

Recalled Item: FastStat Topical Hemostat Introductory Kit Recalled by CAO Group, Inc. Due...

The Issue: cGMP violations noted during the firm's most recent inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund